Market LIVE
Published markets; coverage varies by country
Product profile · United States

ROZLYTREK

 ·  Patent Litigation & Settlement History ↓

IngredientENTRECTINIB
Application typeNDA
Application212725
Product002
Dosage formCAPSULE
RouteORAL
Strength200MG
Approval date2019-08-15
Marketing statusPrescription
Status event—
ApplicantGENENTECH INC
Product source

Current GenericRadar decision

Year2035
SelectionDEEP_REVIEW
ReviewFINAL
Anchor typePATENT
Anchor date2035-02-17
Patent anchor2035-02-17
Exclusivity anchor2026-08-15
Protection date2038-07-18
First Final ANDA—
Status event—

GNR judgment: DEEP_REVIEW. Reference year: 2035. Anchor type: PATENT. Patent anchor: 2035-02-17. Exclusivity anchor: 2026-08-15. Anchor date: 2035-02-17. Patent tail: yes. Exclusivity tail: no. Review status: FINAL. Historical detailed rationale is retained in the evidence snapshot; this is a structured English summary, not a literal translation.

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
86738932028-07-08U U-2617NNU
English description not available.
———
86738932028-07-08U U-2618NNU
English description not available.
———
86738932028-07-08ORANGE_BOOK U-2617;U-2618NNU
English description not available.
———
90293562028-07-08DS/DP —YNTRUE_DS
English description not available.
———
90293562028-07-08ORANGE_BOOK —YNTRUE_DS
English description not available.
———
90855582028-07-08DP —NNDP
English description not available.
———
90855582028-07-08ORANGE_BOOK —NNDP
English description not available.
———
92550872028-07-08U U-2618NNU
English description not available.
———
92550872028-07-08U U-2617NNU
English description not available.
———
92550872028-07-08ORANGE_BOOK U-2617;U-2618NNU
English description not available.
———
96160592028-07-08U U-2618NNU
English description not available.
———
96160592028-07-08ORANGE_BOOK U-2618NNU
English description not available.
———
82990572032-03-10DS/DP —YNTRUE_DS
English description not available.
———
82990572032-03-10ORANGE_BOOK —YNTRUE_DS
English description not available.
———
90855652033-05-22DS/DP —NNDP
English description not available.
———
90855652033-05-22ORANGE_BOOK —NNDP
English description not available.
———
96493062033-05-22U U-2618NNU
English description not available.
———
96493062033-05-22U U-2617NNU
English description not available.
———
96493062033-05-22ORANGE_BOOK U-2617;U-2618NNU
English description not available.
———
102319652035-02-17U U-2618NYU
English description not available.
———
102319652035-02-17U U-2617NYU
English description not available.
———
102319652035-02-17ORANGE_BOOK U-2617;U-2618NYU
English description not available.
———
105616512035-02-19U U-2745NNU
English description not available.
———
105616512035-02-19ORANGE_BOOK U-2745NNU
English description not available.
———
107380372037-05-18DS/DP/U U-2946NNDP
English description not available.
———
107380372037-05-18ORANGE_BOOK U-2946NNDP
English description not available.
———
110914692037-05-18U U-2618NNU
English description not available.
———
110914692037-05-18U U-2617NNU
English description not available.
———
110914692037-05-18ORANGE_BOOK U-2617;U-2618NNU
English description not available.
———
103986932038-07-18DP —NNDP
English description not available.
———
103986932038-07-18ORANGE_BOOK —NNDP
English description not available.
———
112535152038-07-18DP —NNDP
English description not available.
———
112535152038-07-18ORANGE_BOOK —NNDP
English description not available.
———

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
NCE2019-08-152024-08-15English description not available.YY2024-08-15
ODE-265 + ODE-313 + ODE-448
Full coverage date: 2024-08-15
Source
ODE-2652019-08-152026-08-15English description not available.NN——Source
ODE-2652019-08-152026-08-15English description not available.NN—
ODE-265 + ODE-313 + ODE-448
Full coverage date: —
Source
ODE-3132019-08-152026-08-15English description not available.NN——Source
ODE-3132019-08-152026-08-15English description not available.NN—
ODE-265 + ODE-313 + ODE-448
Full coverage date: —
Source
NPP2023-10-202026-10-20English description not available.NN——Source
NPP2023-10-202026-10-20English description not available.NN—
ODE-265 + ODE-313 + ODE-448
Full coverage date: —
Source
ODE-4482023-10-202030-10-20English description not available.NN——Source
ODE-4482023-10-202030-10-20English description not available.NN—
ODE-265 + ODE-313 + ODE-448
Full coverage date: —
Source

2026-10-10 · CURRENT_SOURCE_RECORDS_FOUND · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
No generic approval facts are linked to this product.

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 0 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
No final-approval records are linked to this product.
Decision evidence (20)
TypeDateRoleBasisSource
PATENT2028-07-08HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2028-07-08HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2028-07-08HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2028-07-08HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2028-07-08HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2032-03-10HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2033-05-22HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2033-05-22HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2035-02-17CANONICAL_ANCHOREnglish description not available.Source
PATENT2035-02-19FTO_TAILEnglish description not available.Source
PATENT2037-05-18FTO_TAILEnglish description not available.Source
PATENT2037-05-18FTO_TAILEnglish description not available.Source
PATENT2038-07-18FTO_TAILEnglish description not available.Source
PATENT2038-07-18FTO_TAILEnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_STATUS2035-02-17CANONICAL_DECISIONEnglish description not available.Source
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.